デフォルト表紙
市場調査レポート
商品コード
1519371

ポイントオブケア診断薬市場レポート:製品タイプ、プラットフォーム、処方形態、エンドユーザー、地域別、2024年~2032年

Point-of-Care Diagnostics Market Report by Product Type, Platform, Prescription Mode, End-User, and Region 2024-2032

出版日: | 発行: IMARC | ページ情報: 英文 148 Pages | 納期: 2~3営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報(例:国別セグメント)の追加などの対応が可能です。  詳細はお問い合わせください。

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=150.67円
ポイントオブケア診断薬市場レポート:製品タイプ、プラットフォーム、処方形態、エンドユーザー、地域別、2024年~2032年
出版日: 2024年07月01日
発行: IMARC
ページ情報: 英文 148 Pages
納期: 2~3営業日
  • 全表示
  • 概要
  • 図表
  • 目次
概要

世界のポイントオブケア診断薬市場規模は2023年に492億米ドルに達しました。今後、IMARC Groupは、市場は2032年までに995億米ドルに達し、2024年から2032年の間に7.9%の成長率(CAGR)を示すと予測しています。より迅速で利便性の高い診断ソリューションに対する需要の高まり、世界の感染症流行の高まり、技術および小型化の進歩が市場を牽引する主な要因の一例です。

ポイントオブケア診断薬市場分析:

市場の成長と規模世界のポイントオブケア診断薬市場は、大衆の間で様々な慢性疾患の発生が増加していることから、緩やかな成長を遂げています。

主な市場促進要因:主な要因:ポイントオブケア(POC)ツールの開発拡大、患者の予後改善のための個別化医療への注目の高まりなど。

主要市場動向:主な動向には、遠隔地でのヘルスケアサービス提供のための高度な検査ソリューションやポータブルPOC検査システム開発のための研究活動への投資が含まれます。

地域別動向:北米が市場を独占しており、これはヘルスケア分野への投資増加によるものです。しかし、アジア太平洋地域は、大衆の間で慢性疾患の発生が増加していることから、急成長市場として浮上しています。

競合情勢:ポイントオブケア診断業界の主な市場プレイヤーとしては、アボット・ラボラトリーズ、ベックマン・コールター、ベクトン・ディッキンソン・アンド・カンパニー、F.ホフマン・ラ・ロシュAGなどが挙げられます。これらの企業は研究開発(R&D)に投資し、世界のプレゼンスを拡大し、高度な検査ソリューションの開発に注力しています。

課題と機会:課題には、高精度とコスト効率の高いソリューションの必要性が含まれます。とはいえ、個別化医療の利点に対する意識の高まりにより、これらの課題は克服されると予測されます。

ポイントオブケア診断薬市場傾向/促進要因:

慢性疾患の蔓延

世界保健機関(WHO)によると、慢性疾患とも呼ばれる非感染性疾患によって毎年4,100万人が死亡しており、これは世界全体の死亡者数の74%に相当します。慢性疾患の世界の増加は、POC診断サービスの需要を促進しています。糖尿病、心血管疾患、呼吸器疾患などの慢性疾患は大衆の間でますます蔓延しており、世界中のヘルスケアシステムに大きな課題を突きつけています。POC診断は、これらの健康合併症の自発的な検出と継続的なモニタリングのための貴重なツールを提供し、タイムリーな介入と効果的な疾病管理を促進します。POC検査の利便性と入手の容易さは、特に従来の検査施設へのアクセスが制限されていたり、利用できなかったりする遠隔地や農村部での慢性疾患の管理にさらに貢献します。このように、慢性疾患の有病率の増加が、世界中でPOC検査の需要を牽引しています。

様々な技術的進歩

技術革新と統合は、ポイントオブケア診断薬市場の成長を支える上で重要な役割を果たしています。小型化、バイオセンサー、コネクティビティへの取り組みや調査により、様々なスマートでポータブルな診断機器やシステムが生み出されています。これらのPOC機器は、従来の検査室ベースの方法ではしばしば実現できなかった幅広い検査を高い精度で行うことができます。また、複数の機器を必要とせず、検査結果を得るまでの所要時間を短縮するために、拡張された検査メニューと統合されていることも多いです。

各社はまた、コンパクトなサイズで包括的な検査設備を提供するPOC診断システムの製造も計画しています。市場の主要企業は、ヘルスケア提供に革命を起こすために、ユニークで信頼性の高い診断ソリューションを提供するために、他の企業とも協力しています。モルビオ・ダイアグノスティックスは2023年にSigTuple社との提携を宣言し、多くのルーチン検査や診断検査に対応する次世代のAI対応ポータブル機器を開発します。

個別化医療重視の高まり

大衆の間で個別化医療へのニーズが高まっていることが、市場の成長を後押ししています。米国国立がん研究所(NCI)は、さまざまな新規薬剤の組み合わせによる小児および成人の治療効果を調べるため、大規模な精密医療がんイニシアチブを立ち上げました。

さらに、ヘルスケア部門がより患者中心のアプローチに移行しつつある中、個別化医療の受け入れが患者のニーズに応じた治療計画の作成を促進しています。POC診断薬は、迅速かつ的を絞った診断ソリューションを提供し、正確な疾患の特定とモニタリングを支援するため、この手順において極めて重要な役割を果たしています。POC診断薬は、治療や全般的な健康状態に関して患者に安心感を与えるものであり、これが患者から高い支持を得ている理由でもあります。さらに、コリエル・ライフサイエンス社の調査によると、精密医療は世界の採用の転換期に達していることが確認されています。

目次

第1章 序文

第2章 調査範囲と調査手法

  • 調査の目的
  • ステークホルダー
  • データソース
    • 一次情報
    • 二次情報
  • 市場推定
    • ボトムアップアプローチ
    • トップダウンアプローチ
  • 調査手法

第3章 エグゼクティブサマリー

第4章 イントロダクション

  • 概要
  • 主要業界動向

第5章 世界のポイントオブケア診断薬市場

  • 市場概要
  • 市場実績
  • COVID-19の影響
  • 市場予測

第6章 市場内訳:製品タイプ別

  • 血糖値モニタリングキット
    • 市場動向
    • 市場予測
  • 心臓代謝モニタリングキット
    • 市場動向
    • 市場予測
  • 妊娠・不妊検査キット
    • 市場動向
    • 市場予測
  • 感染症検査キット
    • 市場動向
    • 市場予測
  • コレステロール検査ストリップ
    • 市場動向
    • 市場予測
  • 血液検査キット
    • 市場動向
    • 市場予測
  • その他
    • 市場動向
    • 市場予測

第7章 市場内訳:プラットフォーム別

  • ラテラルフローアッセイ
    • 市場動向
    • 市場予測
  • ディップスティック
    • 市場動向
    • 市場予測
  • マイクロ流体
    • 市場動向
    • 市場予測
  • 分子診断
    • 市場動向
    • 市場予測
  • 免疫学的検査
    • 市場動向
    • 市場予測

第8章 市場内訳:処方形態別

  • 処方箋に基づく検査
    • 市場動向
    • 市場予測
  • OTC検査
    • 市場動向
    • 市場予測

第9章 市場内訳:エンドユーザー別

  • 専門診断センター
    • 市場動向
    • 市場予測
  • ホームケア
    • 市場動向
    • 市場予測
  • ラボ
    • 市場動向
    • 市場予測
  • その他
    • 市場動向
    • 市場予測

第10章 市場内訳:地域別

  • 北米
    • 米国
    • カナダ
  • アジア太平洋
    • 中国
    • 日本
    • インド
    • 韓国
    • オーストラリア
    • インドネシア
    • その他
  • 欧州
    • ドイツ
    • フランス
    • 英国
    • イタリア
    • スペイン
    • ロシア
    • その他
  • ラテンアメリカ
    • ブラジル
    • メキシコ
    • その他
  • 中東・アフリカ
    • 市場動向
    • 市場内訳:国別
    • 市場予測

第11章 SWOT分析

  • 概要
  • 強み
  • 弱み
  • 機会
  • 脅威

第12章 バリューチェーン分析

第13章 ポーターのファイブフォース分析

  • 概要
  • 買い手の交渉力
  • 供給企業の交渉力
  • 競合の程度
  • 新規参入業者の脅威
  • 代替品の脅威

第14章 価格指標

第15章 競合情勢

  • 市場構造
  • 主要企業
  • 主要企業のプロファイル
    • Abbott Laboratories
    • Beckman Coulter Inc.
    • Becton, Dickinson and Company
    • F. Hoffmann-La Roche AG
    • Instrumentation Laboratory
    • Johnson & Johnson
    • Nova Biomedical Corporation
    • Pts Diagnostics
    • Qiagen
    • Siemens
    • Trinity Biotech
図表

List of Figures

  • Figure 1: Global: Point-of-Care Diagnostics Market: Major Drivers and Challenges
  • Figure 2: Global: Point-of-Care Diagnostics Market: Sales Value (in Billion US$), 2018-2023
  • Figure 3: Global: Point-of-Care Diagnostics Market: Breakup by Product Type (in %), 2023
  • Figure 4: Global: Point-of-Care Diagnostics Market: Breakup by Platform (in %), 2023
  • Figure 5: Global: Point-of-Care Diagnostics Market: Breakup by Prescription Mode (in %), 2023
  • Figure 6: Global: Point-of-Care Diagnostics Market: Breakup by End-User (in %), 2023
  • Figure 7: Global: Point-of-Care Diagnostics Market: Breakup by Region (in %), 2023
  • Figure 8: Global: Point-of-Care Diagnostics Market Forecast: Sales Value (in Billion US$), 2024-2032
  • Figure 9: Global: Point-of-Care Diagnostics (Blood-Glucose Monitoring Kit) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 10: Global: Point-of-Care Diagnostics (Blood-Glucose Monitoring Kit) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 11: Global: Point-of-Care Diagnostics (Cardio-Metabolic Monitoring Kit) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 12: Global: Point-of-Care Diagnostics (Cardio-Metabolic Monitoring Kit) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 13: Global: Point-of-Care Diagnostics (Pregnancy and Fertility Testing Kit) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 14: Global: Point-of-Care Diagnostics (Pregnancy and Fertility Testing Kit) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 15: Global: Point-of-Care Diagnostics (Infectious Disease Testing Kit) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 16: Global: Point-of-Care Diagnostics (Infectious Disease Testing Kit) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 17: Global: Point-of-Care Diagnostics (Cholesterol Test Strip) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 18: Global: Point-of-Care Diagnostics (Cholesterol Test Strip) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 19: Global: Point-of-Care Diagnostics (Hematology Testing Kit) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 20: Global: Point-of-Care Diagnostics (Hematology Testing Kit) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 21: Global: Point-of-Care Diagnostics (Other Product Types) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 22: Global: Point-of-Care Diagnostics (Other Product Types) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 23: Global: Point-of-Care Diagnostics (Lateral Flow Assays) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 24: Global: Point-of-Care Diagnostics (Lateral Flow Assays) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 25: Global: Point-of-Care Diagnostics (Dipsticks) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 26: Global: Point-of-Care Diagnostics (Dipsticks) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 27: Global: Point-of-Care Diagnostics (Microfluidics) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 28: Global: Point-of-Care Diagnostics (Microfluidics) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 29: Global: Point-of-Care Diagnostics (Molecular Diagnostics) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 30: Global: Point-of-Care Diagnostics (Molecular Diagnostics) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 31: Global: Point-of-Care Diagnostics (Immunoassays) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 32: Global: Point-of-Care Diagnostics (Immunoassays) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 33: Global: Point-of-Care Diagnostics (Prescription-Based Testing) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 34: Global: Point-of-Care Diagnostics (Prescription-Based Testing) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 35: Global: Point-of-Care Diagnostics (OTC Testing) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 36: Global: Point-of-Care Diagnostics (OTC Testing) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 37: Global: Point-of-Care Diagnostics (Professional Diagnostic Centers) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 38: Global: Point-of-Care Diagnostics (Professional Diagnostic Centers) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 39: Global: Point-of-Care Diagnostics (Home Care) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 40: Global: Point-of-Care Diagnostics (Home Care) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 41: Global: Point-of-Care Diagnostics (Research Laboratories) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 42: Global: Point-of-Care Diagnostics (Research Laboratories) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 43: Global: Point-of-Care Diagnostics (Other End-Users) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 44: Global: Point-of-Care Diagnostics (Other End-Users) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 45: North America: Point-of-Care Diagnostics Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 46: North America: Point-of-Care Diagnostics Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 47: United States: Point-of-Care Diagnostics Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 48: United States: Point-of-Care Diagnostics Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 49: Canada: Point-of-Care Diagnostics Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 50: Canada: Point-of-Care Diagnostics Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 51: Asia Pacific: Point-of-Care Diagnostics Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 52: Asia Pacific: Point-of-Care Diagnostics Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 53: China: Point-of-Care Diagnostics Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 54: China: Point-of-Care Diagnostics Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 55: Japan: Point-of-Care Diagnostics Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 56: Japan: Point-of-Care Diagnostics Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 57: India: Point-of-Care Diagnostics Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 58: India: Point-of-Care Diagnostics Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 59: South Korea: Point-of-Care Diagnostics Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 60: South Korea: Point-of-Care Diagnostics Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 61: Australia: Point-of-Care Diagnostics Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 62: Australia: Point-of-Care Diagnostics Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 63: Indonesia: Point-of-Care Diagnostics Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 64: Indonesia: Point-of-Care Diagnostics Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 65: Others: Point-of-Care Diagnostics Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 66: Others: Point-of-Care Diagnostics Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 67: Europe: Point-of-Care Diagnostics Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 68: Europe: Point-of-Care Diagnostics Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 69: Germany: Point-of-Care Diagnostics Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 70: Germany: Point-of-Care Diagnostics Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 71: France: Point-of-Care Diagnostics Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 72: France: Point-of-Care Diagnostics Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 73: United Kingdom: Point-of-Care Diagnostics Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 74: United Kingdom: Point-of-Care Diagnostics Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 75: Italy: Point-of-Care Diagnostics Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 76: Italy: Point-of-Care Diagnostics Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 77: Spain: Point-of-Care Diagnostics Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 78: Spain: Point-of-Care Diagnostics Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 79: Russia: Point-of-Care Diagnostics Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 80: Russia: Point-of-Care Diagnostics Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 81: Others: Point-of-Care Diagnostics Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 82: Others: Point-of-Care Diagnostics Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 83: Latin America: Point-of-Care Diagnostics Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 84: Latin America: Point-of-Care Diagnostics Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 85: Brazil: Point-of-Care Diagnostics Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 86: Brazil: Point-of-Care Diagnostics Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 87: Mexico: Point-of-Care Diagnostics Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 88: Mexico: Point-of-Care Diagnostics Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 89: Others: Point-of-Care Diagnostics Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 90: Others: Point-of-Care Diagnostics Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 91: Middle East and Africa: Point-of-Care Diagnostics Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 92: Middle East and Africa: Point-of-Care Diagnostics Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 93: Global: Point-of-Care Diagnostics Industry: SWOT Analysis
  • Figure 94: Global: Point-of-Care Diagnostics Industry: Value Chain Analysis
  • Figure 95: Global: Point-of-Care Diagnostics Industry: Porter's Five Forces Analysis

List of Tables

  • Table 1: Global: Point-of-Care Diagnostics Market: Key Industry Highlights, 2023 and 2032
  • Table 2: Global: Point-of-Care Diagnostics Market Forecast: Breakup by Product Type (in Million US$), 2024-2032
  • Table 3: Global: Point-of-Care Diagnostics Market Forecast: Breakup by Platform (in Million US$), 2024-2032
  • Table 4: Global: Point-of-Care Diagnostics Market Forecast: Breakup by Prescription Mode (in Million US$), 2024-2032
  • Table 5: Global: Point-of-Care Diagnostics Market Forecast: Breakup by End-User (in Million US$), 2024-2032
  • Table 6: Global: Point-of-Care Diagnostics Market Forecast: Breakup by Region (in Million US$), 2024-2032
  • Table 7: Global: Point-of-Care Diagnostics Market: Competitive Structure
  • Table 8: Global: Point-of-Care Diagnostics Market: Key Players
目次
Product Code: SR112024A2113

The global point-of-care diagnostics market size reached US$ 49.2 Billion in 2023. Looking forward, IMARC Group expects the market to reach US$ 99.5 Billion by 2032, exhibiting a growth rate (CAGR) of 7.9% during 2024-2032. The increasing demand for faster and more convenient diagnostic solutions, rising prevalence of infectious diseases across the globe, and advancements in technology and miniaturization represent some of the key factors driving the market.

Point-of-Care Diagnostics Market Analysis:

Market Growth and Size: The global point-of-care diagnostics market is experiencing moderate growth, on account of the increasing occurrence of various chronic diseases among the masses.

Major Market Drivers: Key factors include the growing development of point-of-care tools and the rising focus on personalized medicine for better patient outcomes.

Key Market Trends: Major trends include investments in research activities to develop advanced testing solutions and portable point-of-care testing systems for providing healthcare services in remote areas.

Geographical Trends: North America dominates the market, driven by rising investments in the healthcare sector. However, Asia Pacific is emerging as a fastest-growing market on account of the rising occurrence of chronic diseases among the masses.

Competitive Landscape: Some of the major market players in the point-of-care diagnostics industry include Abbott Laboratories, Beckman Coulter, Inc., Becton, Dickinson and Company, F. Hoffmann-La Roche AG, among many others. These companies are investing in research and development (R&D), expanding their global presence, and focusing on the development of advanced testing solutions.

Challenges and Opportunities: Challenges include the need for high accuracy and cost-effective solutions. Nonetheless, the rising awareness about the benefits of personalized medicines is projected to overcome these challenges.

Point-of-Care Diagnostics Market Trends/Drivers:

The growing prevalence of chronic diseases

According to the World Health Organization (WHO), non-communicable diseases, also called chronic diseases, kill 41 million people each year, which is equivalent to 74% of all deaths globally. The global rise in chronic diseases is driving the demand for POC diagnostic services. Chronic conditions, such as diabetes, cardiovascular diseases, and respiratory disorders, are becoming increasingly prevalent among the masses, posing substantial challenges to healthcare systems worldwide. POC diagnostics offer a valuable tool for spontaneous detection and continuous monitoring of these health complications, facilitating timely interventions and effective disease management. The convenience and easy availability of POC testing further contribute to the management of chronic diseases, especially in remote or rural areas where access to traditional laboratory facilities is limited or not available. Thus, the growing prevalence of chronic diseases is driving the point-of-care diagnostics demand around the world.

Various technological advancements

Technological innovations and integration play a crucial role in supporting the point-of-care diagnostics market growth. Initiatives and research in miniaturization, biosensors, and connectivity are leading to the creation of various smart and portable diagnostic devices and systems. These POC devices can perform a wide range of tests with high accuracy, which traditional laboratory-based methods often fail to deliver. They are also often integrated with expanded test menus to eliminate the need for multiple devices and reduce turnaround time for getting the test results.

Companies are also planning to produce POC diagnostics systems which are compact in size and offer comprehensive testing facilities. Key market players are also collaborating with other firms to offer unique and reliable diagnostic solutions to revolutionize healthcare delivery. Molbio Diagnostics declared its partnership with SigTuple in 2023 to develop next-generation AI-enabled portable devices for many routine and diagnostic tests.

The growing emphasis on personalized medicine

The increasing need for personalized medicine among the masses is propelling the growth of the market. The National Cancer Institute (NCI) has launched a large precision medicine cancer initiative to examine the effectiveness of treating children and adults with various novel drug combinations.

Moreover, as the healthcare sector is transitioning towards a more patient-centric approach, the acceptance of personalized medicine is facilitating the creation of treatment plans according to the needs of patients. POC diagnostics play a pivotal part in this procedure as it offers rapid and targeted diagnostic solutions that aid in precise disease identification and monitoring. They provide a sense of assurance to patients regarding their treatment and overall wellbeing, which is also responsible for their high acceptance among patients. Moreover, according to research done by Coriell Life Sciences, it is confirmed that precision medicine has reached a global tipping position for adoption.

Point-of-Care Diagnostics Industry Segmentation:

IMARC Group provides an analysis of the key trends in each segment of the global point-of-care diagnostics market report, along with forecasts at the global, regional, and country levels from 2024-2032. Our report has categorized the market based on product type, platform, prescription mode, and end-user.

Breakup by Product Type:

Blood-Glucose Monitoring Kit

Cardio-Metabolic Monitoring Kit

Pregnancy and Fertility Testing Kit

Infectious Disease Testing Kit

Cholesterol Test Strip

Hematology Testing Kit

Others

Blood-glucose monitoring kit represents the most popular product type

The report has provided a detailed breakup and analysis of the market based on product type. This includes blood-glucose monitoring kit, cardio-metabolic monitoring kit, pregnancy and fertility testing kit, infectious disease testing kit, cholesterol test strip, hematology testing kit, and others. According to the report, blood-glucose monitoring kit represented the largest segment.

Blood-glucose monitoring kits are designed to be user-friendly, allowing patients to perform tests themselves without the need for specialized medical training. The simplicity and convenience of these kits are contributing to their widespread adoption, making them accessible to a broad spectrum of patients, including those in remote or underserved areas. Moreover, blood-glucose monitoring kits are often compact and portable, enabling patients to carry them wherever they go, thereby offering a favorable point-of-care diagnostics market outlook. Furthermore, on the basis of the predictions and research by the Institute for Health Metrics and Evaluation, global diabetes cases will increase from 529 million to 1.3 billion by 2050. The US Food and Drug Administration cleared the first over-the-counter (OTC) continuous glucose monitoring system (CGM) in the US -- the Dexcom Stelo Glucose Biosensor System. This will help people with Type 2 diabetes who don't need insulin to track their blood sugar for nonmedical purposes.

Breakup by Platform:

Lateral Flow Assays

Dipsticks

Microfluidics

Molecular Diagnostics

Immunoassays

Lateral flow assays represent the leading platform

A detailed breakup and analysis of the market based on the platform has also been provided in the report. This includes lateral flow assays, dipsticks, microfluidics, molecular diagnostics, and immunoassays. According to the report, lateral flow assays hold the largest point-of-care diagnostics market share.

Lateral flow assays are known for their "simplicity" and "user-friendly" design. They are easy to use, requiring minimal training for both healthcare professionals and patients. The test procedure typically involves incorporating a samples like blood, saliva, and urine to a test strip, and the results are visually interpreted through the appearance of colored lines, eliminating the need for complex laboratory equipment. They offer stability over a wide range of environmental conditions and have a long shelf life. They also require small sample volume to conduct tests. As a result, various organizations and institutions are investing in the development of advanced lateral flow assays. For example, iiCON announced in 2021 that it will support Liverpool SME to develop advanced lateral flow tests, which can be performed with and without the addition of the Nano Biosols reagent.

Breakup by Prescription Mode:

Prescription-Based Testing

OTC Testing

Prescription-based testing currently dominates the market

The report has provided a detailed breakup and analysis of the market based on prescription mode. This includes prescription-based testing and OTC testing. According to the report, prescription-based testing represented the largest segment.

Prescription-based testing involves diagnostic tests that require a healthcare professional's order or prescription before they can be performed. These tests often undergo rigorous regulatory approval processes to ensure their safety, efficacy, and accuracy. The involvement of healthcare professionals in prescribing these tests ensures appropriate medical supervision and interpretation of the results, leading to better patient care and treatment decisions. Prescription-based testing is essential for the accurate detection, staging, and monitoring of diseases such as cancer, infectious diseases, cardiovascular disorders, and autoimmune conditions. As per the reports of WHO, over 35 million new cancer cases are predicted in 2050. This will further increase the need for prescription-based testing solutions.

Breakup by End-User:

Professional Diagnostic Centers

Home Care

Research Laboratories

Others

Professional diagnostic centers account for the majority of the market share

A detailed breakup and analysis of the market based on the end user has also been provided in the report. This includes professional diagnostic centers, home care, research laboratories, and others. According to the report, professional diagnostic centers accounted for the largest market share.

Professional diagnostic centers offer a wide range of POC diagnostic tests, catering to various medical specialties and healthcare needs. These centers often have advanced equipment and well-trained personnel, allowing them to perform a diverse set of tests, including blood tests, rapid infectious disease testing, urinalysis, pregnancy tests, and more. The availability of comprehensive testing services makes professional diagnostic centers a preferred choice for both patients and healthcare providers. Moreover, professional diagnostic centers are staffed by qualified healthcare professionals, including medical technologists, clinical laboratory scientists, and physicians.

According to a report by the United Nations Economic and Social Commission for Asia and the Pacific (ESCAP), the Asia-Pacific Trade and Investment Trends 2022/2023 demonstrates that the pharmaceutical industry attracted the highest amount of FDI ($32 billion) between 2008 to 2021 - significantly more than investments in the medical devices ($20 billion), biotechnology ($17 billion) and healthcare ($10.8 billion) subsectors. This further increased the number of professional diagnostic centers providing comprehensive healthcare services.

Breakup by Region:

North America

United States

Canada

Asia Pacific

China

Japan

India

South Korea

Australia

Indonesia

Others

Europe

Germany

France

United Kingdom

Italy

Spain

Russia

Others

Latin America

Brazil

Mexico

Others

Middle East and Africa

North America exhibits a clear dominance in the market

The report has also provided a comprehensive analysis of all the major regional markets, which include North America (United States, Canada); Asia-Pacific (China, Japan, India, South Korea, Australia, Indonesia, Others); Europe (Germany, France, United Kingdom, Italy, Spain, Russia, Others); Latin America (Brazil, Mexico, Others); and the Middle East and Africa. According to the report, North America was the largest market for point-of-care diagnostics.

North America boasts a highly developed healthcare infrastructure with well-established medical facilities, laboratories, and diagnostic centers. The robust healthcare system of the region enables widespread adoption and integration of POC diagnostics into routine medical practice, contributing to their market dominance. Besides this, the high prevalence of chronic diseases, such as diabetes, cardiovascular disorders, and respiratory conditions, is driving the demand for comprehensive testing services. POC diagnostics play a crucial role in the early detection, monitoring, and management of these chronic conditions.

As per a press release by the Centers for Disease Control and Prevention, the number of Americans with diabetes will range between 1 in 3 to 1 in 5 by 2050. This will further increase the demand for point-of-care testing solutions in the region.

Competitive Landscape:

The competitive landscape of the market is dynamic and characterized by the presence of numerous players, including established companies, emerging startups, and specialized firms and effective in answering queries related to how big is the point-of-care diagnostics market? Major players are heavily investing in R&D to innovate and develop cutting-edge POC diagnostic solutions. They are also focusing on improving the accuracy, sensitivity, and speed of their tests. Top companies are expanding the range of analytes and diseases that can be detected using POC devices. R&D efforts also involve exploring new technologies, such as biosensors, microfluidics, and lab-on-a-chip systems, to enhance the performance of POC diagnostics. They are also tailoring their products and marketing strategies to meet the specific healthcare needs and regulatory requirements of different countries. For example, Cipla launched a point-of-care testing device for various non-communicable diseases and other medical conditions as an addition to its product offerings. The point-of-care diagnostics market statistics indicate a robust expansion trajectory, fueled by rising demands for rapid testing, technological innovation, and a growing emphasis on decentralized healthcare.

The report has provided a comprehensive analysis of the competitive landscape in the market. Detailed profiles of all major companies have also been provided. Some of the key players in the market include:

Abbott Laboratories

Beckman Coulter, Inc.

Becton Dickinson and Company

F. Hoffmann-La Roche AG

Instrumentation Laboratory

Johnson & Johnson

Nova Biomedical Corporation

Pts Diagnostics

Qiagen

Siemens

Trinity Biotech

(Please note that this is only a partial list of the key players, and the complete list is provided in the report.)

Recent Developments:

January 2023: Beckman Coulter, Inc. announced that it has entered a strategic partnership with MeMed to develop and commercialize a host immune response diagnostic test.

January 2023: Becton Dickinson and Company presented educational grant funding towards 19 to Zero for a point-of-care testing pilot in the primary care setting.

Key Questions Answered in This Report

  • 1. What is the global point-of-care diagnostics market growth?
  • 2. What are the global point-of-care diagnostics market drivers?
  • 3. What are the key industry trends in the global point-of-care diagnostics market?
  • 4. What is the impact of COVID-19 on the global point-of-care diagnostics market?
  • 5. What is the global point-of-care diagnostics market breakup by product type?
  • 6. What are the major regions in the global point-of-care diagnostics market?
  • 7. Who are the key companies/players in the global point-of-care diagnostics market?

Table of Contents

1 Preface

2 Scope and Methodology

  • 2.1 Objectives of the Study
  • 2.2 Stakeholders
  • 2.3 Data Sources
    • 2.3.1 Primary Sources
    • 2.3.2 Secondary Sources
  • 2.4 Market Estimation
    • 2.4.1 Bottom-Up Approach
    • 2.4.2 Top-Down Approach
  • 2.5 Forecasting Methodology

3 Executive Summary

4 Introduction

  • 4.1 Overview
  • 4.2 Key Industry Trends

5 Global Point-of-Care Diagnostics Market

  • 5.1 Market Overview
  • 5.2 Market Performance
  • 5.3 Impact of COVID-19
  • 5.4 Market Forecast

6 Market Breakup by Product Type

  • 6.1 Blood-Glucose Monitoring Kit
    • 6.1.1 Market Trends
    • 6.1.2 Market Forecast
  • 6.2 Cardio-Metabolic Monitoring Kit
    • 6.2.1 Market Trends
    • 6.2.2 Market Forecast
  • 6.3 Pregnancy and Fertility Testing Kit
    • 6.3.1 Market Trends
    • 6.3.2 Market Forecast
  • 6.4 Infectious Disease Testing Kit
    • 6.4.1 Market Trends
    • 6.4.2 Market Forecast
  • 6.5 Cholesterol Test Strip
    • 6.5.1 Market Trends
    • 6.5.2 Market Forecast
  • 6.6 Hematology Testing Kit
    • 6.6.1 Market Trends
    • 6.6.2 Market Forecast
  • 6.7 Others
    • 6.7.1 Market Trends
    • 6.7.2 Market Forecast

7 Market Breakup by Platform

  • 7.1 Lateral Flow Assays
    • 7.1.1 Market Trends
    • 7.1.2 Market Forecast
  • 7.2 Dipsticks
    • 7.2.1 Market Trends
    • 7.2.2 Market Forecast
  • 7.3 Microfluidics
    • 7.3.1 Market Trends
    • 7.3.2 Market Forecast
  • 7.4 Molecular Diagnostics
    • 7.4.1 Market Trends
    • 7.4.2 Market Forecast
  • 7.5 Immunoassays
    • 7.5.1 Market Trends
    • 7.5.2 Market Forecast

8 Market Breakup by Prescription Mode

  • 8.1 Prescription-Based Testing
    • 8.1.1 Market Trends
    • 8.1.2 Market Forecast
  • 8.2 OTC Testing
    • 8.2.1 Market Trends
    • 8.2.2 Market Forecast

9 Market Breakup by End-User

  • 9.1 Professional Diagnostic Centers
    • 9.1.1 Market Trends
    • 9.1.2 Market Forecast
  • 9.2 Home Care
    • 9.2.1 Market Trends
    • 9.2.2 Market Forecast
  • 9.3 Research Laboratories
    • 9.3.1 Market Trends
    • 9.3.2 Market Forecast
  • 9.4 Others
    • 9.4.1 Market Trends
    • 9.4.2 Market Forecast

10 Market Breakup by Region

  • 10.1 North America
    • 10.1.1 United States
      • 10.1.1.1 Market Trends
      • 10.1.1.2 Market Forecast
    • 10.1.2 Canada
      • 10.1.2.1 Market Trends
      • 10.1.2.2 Market Forecast
  • 10.2 Asia Pacific
    • 10.2.1 China
      • 10.2.1.1 Market Trends
      • 10.2.1.2 Market Forecast
    • 10.2.2 Japan
      • 10.2.2.1 Market Trends
      • 10.2.2.2 Market Forecast
    • 10.2.3 India
      • 10.2.3.1 Market Trends
      • 10.2.3.2 Market Forecast
    • 10.2.4 South Korea
      • 10.2.4.1 Market Trends
      • 10.2.4.2 Market Forecast
    • 10.2.5 Australia
      • 10.2.5.1 Market Trends
      • 10.2.5.2 Market Forecast
    • 10.2.6 Indonesia
      • 10.2.6.1 Market Trends
      • 10.2.6.2 Market Forecast
    • 10.2.7 Others
      • 10.2.7.1 Market Trends
      • 10.2.7.2 Market Forecast
  • 10.3 Europe
    • 10.3.1 Germany
      • 10.3.1.1 Market Trends
      • 10.3.1.2 Market Forecast
    • 10.3.2 France
      • 10.3.2.1 Market Trends
      • 10.3.2.2 Market Forecast
    • 10.3.3 United Kingdom
      • 10.3.3.1 Market Trends
      • 10.3.3.2 Market Forecast
    • 10.3.4 Italy
      • 10.3.4.1 Market Trends
      • 10.3.4.2 Market Forecast
    • 10.3.5 Spain
      • 10.3.5.1 Market Trends
      • 10.3.5.2 Market Forecast
    • 10.3.6 Russia
      • 10.3.6.1 Market Trends
      • 10.3.6.2 Market Forecast
    • 10.3.7 Others
      • 10.3.7.1 Market Trends
      • 10.3.7.2 Market Forecast
  • 10.4 Latin America
    • 10.4.1 Brazil
      • 10.4.1.1 Market Trends
      • 10.4.1.2 Market Forecast
    • 10.4.2 Mexico
      • 10.4.2.1 Market Trends
      • 10.4.2.2 Market Forecast
    • 10.4.3 Others
      • 10.4.3.1 Market Trends
      • 10.4.3.2 Market Forecast
  • 10.5 Middle East and Africa
    • 10.5.1 Market Trends
    • 10.5.2 Market Breakup by Country
    • 10.5.3 Market Forecast

11 SWOT Analysis

  • 11.1 Overview
  • 11.2 Strengths
  • 11.3 Weaknesses
  • 11.4 Opportunities
  • 11.5 Threats

12 Value Chain Analysis

13 Porters Five Forces Analysis

  • 13.1 Overview
  • 13.2 Bargaining Power of Buyers
  • 13.3 Bargaining Power of Suppliers
  • 13.4 Degree of Competition
  • 13.5 Threat of New Entrants
  • 13.6 Threat of Substitutes

14 Price Indicators

15 Competitive Landscape

  • 15.1 Market Structure
  • 15.2 Key Players
  • 15.3 Profiles of Key Players
    • 15.3.1 Abbott Laboratories
      • 15.3.1.1 Company Overview
      • 15.3.1.2 Product Portfolio
      • 15.3.1.3 Financials
      • 15.3.1.4 SWOT Analysis
    • 15.3.2 Beckman Coulter Inc.
      • 15.3.2.1 Company Overview
      • 15.3.2.2 Product Portfolio
      • 15.3.2.3 SWOT Analysis
    • 15.3.3 Becton, Dickinson and Company
      • 15.3.3.1 Company Overview
      • 15.3.3.2 Product Portfolio
      • 15.3.3.3 Financials
      • 15.3.3.4 SWOT Analysis
    • 15.3.4 F. Hoffmann-La Roche AG
      • 15.3.4.1 Company Overview
      • 15.3.4.2 Product Portfolio
      • 15.3.4.3 SWOT Analysis
    • 15.3.5 Instrumentation Laboratory
      • 15.3.5.1 Company Overview
      • 15.3.5.2 Product Portfolio
      • 15.3.5.3 SWOT Analysis
    • 15.3.6 Johnson & Johnson
      • 15.3.6.1 Company Overview
      • 15.3.6.2 Product Portfolio
      • 15.3.6.3 Financials
      • 15.3.6.4 SWOT Analysis
    • 15.3.7 Nova Biomedical Corporation
      • 15.3.7.1 Company Overview
      • 15.3.7.2 Product Portfolio
    • 15.3.8 Pts Diagnostics
      • 15.3.8.1 Company Overview
      • 15.3.8.2 Product Portfolio
    • 15.3.9 Qiagen
      • 15.3.9.1 Company Overview
      • 15.3.9.2 Product Portfolio
      • 15.3.9.3 Financials
    • 15.3.10 Siemens
      • 15.3.10.1 Company Overview
      • 15.3.10.2 Product Portfolio
      • 15.3.10.3 Financials
      • 15.3.10.4 SWOT Analysis
    • 15.3.11 Trinity Biotech
      • 15.3.11.1 Company Overview
      • 15.3.11.2 Product Portfolio
      • 15.3.11.3 Financials
      • 15.3.11.4 SWOT Analysis